Generic antidepressant recall due to nitrosamine cancer risk
TL;DR Summary
Breckenridge Pharmaceuticals recalled certain lots of duloxetine (generic Cymbalta) after FDA testing found nitrosamine levels above the agency’s limit, affecting 30 mg (exp. Apr 2027, Lot 241180C) and two 60 mg lots (Feb 2026 Lot 230286C; Feb 2027 Lot 24072lC). Patients should contact their doctor or pharmacist and not stop taking the medication without medical guidance.
- Popular antidepressant recalled over high levels of a cancer-causing compound NBC New York
- Nearly 375,000 bottles of antidepressant recalled over cancer-linked impurity Houston Chronicle
- Nearly 375,000 bottles of popular antidepressant recalled over high levels of carcinogen KVUE
- Antidepressant recalled due to presence of potentially cancer-causing impurity ABC News - Breaking News, Latest News and Videos
- FDA Announces Recall of Popular Antidepressant Over Possible Carcinogen Risk Health: Trusted and Empathetic Health and Wellness Information
Reading Insights
Total Reads
1
Unique Readers
17
Time Saved
3 min
vs 4 min read
Condensed
92%
741 → 56 words
Want the full story? Read the original article
Read on NBC New York